SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193805-18-000516
Filing Date
2018-04-06
Accepted
2018-04-06 16:20:07
Documents
2
Group Members
DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT HIF, L.P.DEERFIELD MGMT III, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.

Document Format Files

Seq Description Document Type Size
1 e617889_sc13d-homo.htm SC 13D 180068
2 e617889_ex99-1.htm EX-99.1 7947
  Complete submission text file 0001193805-18-000516.txt   189546
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13D

Mailing Address 45 WIGGINS AVE. BEDFORD MA 01730
Business Address 45 WIGGINS AVE. BEDFORD MA 01730 857-305-1825
Homology Medicines, Inc. (Subject) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90433 | Film No.: 18743438
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences